Clinical trial
Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
NCT00005981 · Case Comprehensive Cancer Center, Other · Completed
Key facts
| NCT number | NCT00005981 |
|---|---|
| Title | Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer |
| Official title | Phase II Trial of O6Benzylguanine and BCNU in Patients With Colon and Rectal Carcinoma |
| Lead sponsor | Case Comprehensive Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Drug |
| Interventions | O6-benzylguanine, carmustine |
| Enrollment | 13 |
| Start date | Jun 1, 2000 |
| Primary completion | Nov 1, 2003 |
| Completion | Nov 1, 2003 |
| First posted | Jan 27, 2003 |
| Last update posted | Jun 10, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: